jain.com

Additional ~40MW to CoreWeave by end of Q2 2025

Company: Core Scientific

Subject kind
facility timeline
Statement date
2025-05-06
Promised by
2025-06-30
Promised amount
40.0 MW
Current status
outcome unconfirmed

What the later record shows

Outcome not yet confirmed

No passage states how much billable capacity was delivered to CoreWeave by the end of Q2 2025.

Checked October 16, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

Core Scientific says it will deliver an additional approximately 40MW of billable capacity to CoreWeave by the end of the second quarter of 2025.

Source (primary)

core-scientific 8-K exhibit (q12025corescientificinc-ea.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-16)Live source ↗

Quote: “an additional approximately 40MW by the end of this quarter”

How we checked this

Checked on October 17, 2026. The cited source supports every part of this claim.

The release says an additional approximately 40MW will be delivered to CoreWeave by the end of this quarter. Given the May 7, 2025 date and calendar fiscal quarters, that is the second quarter of 2025.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000162828025023161/q12025corescientificinc-ea.htm) in full (26,933 characters, retrieved October 16, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms core-scientific 8-K exhibit (q12025corescientificinc-ea.htm)

Quote: “an additional approximately 40MW by the end of this quarter”

View cached copy (2026-10-16)Live source ↗

Record of changes

October 16, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 16, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.